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Abstract
Background: Hemihyperplasia (hemihypertrophy) is defined as asymmetric body overgrowth of
one or more body parts. Hemihyperplasia can be isolated or be part of well-defined syndromes
such as in the case of Beckwith-Wiedemann syndrome (BWS). Isolated hemihyperplasia is usually
sporadic, but a number of familial occurrences have been described.
Case presentation: We describe a Tunisian family in which three maternal cousins and their
maternal grandfather present with isolated hemihyperplasia.
Conclusions: The etiology of isolated hemihyperplasia is unknown although in BWS, genomic
imprinting has been shown to play a role in the asymmetric overgrowth. Given the similarity
between these two conditions, it is possible that both may share a common pathogenesis. We also
discuss the possible genetic mechanisms leading to the production of hemihyperplasia in this family.
Background
Hemihyperplasia, formerly referred to as hemihypertro-
phy, is an asymmetric overgrowth involving one or more
body parts [1-3]. Hemihyperplasia can be isolated or can
occur as part of a syndrome. There have been several syn-
dromes in which hemihyperplasia has been described,
these include: Beckwith-Wiedemann syndrome (BWS),
Proteus syndrome, Russell-Silver syndrome, Neurofi-
bromatosis type I (NF I) and Klippel-Trénaunay-Weber
syndrome (KTW) [2,3]. All of these conditions have well
characterized features in addition to the hemihyperplasia.
Isolated hemihyperplasia therefore must be differentiated
from overgrowth that is part of a clinically recognized syn-
drome, since there are many prognostic implications for
those individuals with an underlying syndromic
diagnosis.
The prevalence of isolated hemihyperplasia is difficult to
establish accurately, because many cases may be so mild
as not to come to medical attention. The prevalence of
hemihyperplasia has been estimated to be 1 in 13,200 live
births [4]. This figure, however, may not be the most accu-
rate since both isolated and syndromic forms of hemihy-
perplasia were included. Another large study [5] looked at
860,000 inpatient records and found a total of 10 cases
with congenital asymmetry, suggesting that the preva-
lence for hemihyperplasia is approximately 1 in 86,000.
However, several of the patients included in this survey
had other congenital abnormalities, including BWS.
Lastly, a study done in 1980 surveyed 14,430 consecutive
live born infants delivered in a large maternity hospital in
Tokyo and found only one newborn with hemihyperpla-
sia [6]. These are the only epidemiological studies on
hemihyperplasia published in the literature, and given
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their limitations; it is difficult to estimate the real preva-
lence of this disorder in the general population.
When a clinician is faced with the evaluation of a patient
with hemihyperplasia, it is very important to differentiate
the isolated forms of hemihyperplasia from the syndro-
mic ones, since the morbidity risks and follow up
approaches could be significantly different. For example,
Proteus syndrome, KTW and BWS carry different risks and
have very different clinical management issues in compar-
ison to isolated hemihyperplasia. All of these entities are
usually sporadic cases and have a low recurrence risk.
However, there have been several familial cases of BWS
reported in the literature [7]. Isolated hemihyperplasia
(likewise BWS) is usually sporadic with a low recurrence
risk, however, there have been several reports of familial
hemihyperplasia described in the literature with two or
more affected relatives [8-16]. In this manuscript we
describe a Tunisian family with several individuals
affected with isolated hemihyperplasia. In addition, we
have conducted a review of the literature specifically
involving familial occurrences to evaluate the modes of
inheritance that have been described previously, and com-
ment on the possible molecular mechanisms leading to
the occurrence of hemihyperplasia in this family.
Case presentation
The propositus in this family (Patient 1, III:1) is a 2 year-
old Tunisian male who was diagnosed with right-sided
hemihyperplasia. He was being followed by periodic
abdominal ultrasounds every six months to screen for
abdominal tumors. One month prior to our examination
of the patient, three nodules were noted on his kidney by
ultrasonography. Further evaluation revealed he had uni-
lateral Wilms tumor with a negative metastatic work-up.
The patient underwent tumor resection followed by
chemotherapy with good outcome. His medical history
was significant for the diagnosis of hemihyperplasia a few
months after birth. He had no other medical problems
until the development of the Wilms tumor. His birth
weight was 3.6 kg (75th centile). His development has
been normal for age. His physical examination at 2 years
of age revealed: weight 20.9 kg (>95th centile), height 97
cm (>95th centile) and head circumference 55 cm (>95th
centile). His clinical exam revealed hemihyperplasia
involving both his right upper and right lower extremities.
He had a leg-length discrepancy with his right leg being 3
cm longer than the left measured on clinical examination.
His right calf circumference was 26 cm while his left calf
circumference was 23 cm. He had no dysmorphic features
or other abnormal findings on his physical examination.
The neurological exam was normal. Specifically, he had
no macroglossia, history of abdominal wall defects, ear
lobe creases, café-au-lait macules or vascular abnormali-
ties. G-band chromosome analysis performed on periph-
eral blood lymphocytes at approximately 550-band
resolution level was reported as normal. No cytogenetic
abnormalities were detected in the 11p15 region.
Patient 2 is the 5 year-old male maternal first cousin of the
propositus (III:3). He also has been diagnosed with hemi-
hyperplasia and is undergoing tumor screening by serial
abdominal ultrasounds. He has had no signs, symptoms
or radiographic findings suggestive of a neoplasm. His
birth history is non-contributory. His development has
been normal for age. He has hemihyperplasia of the right
upper and lower extremities with a 3.5 cm leg length dis-
crepancy (Figure 1) also recorded on the clinical exam.
Otherwise his physical examination is normal. His neuro-
logical exam was normal as well. G-band chromosome
analysis performed on peripheral blood lymphocytes, at
approximately 550-band resolution level, was also
reported as normal. Like in our previous case, no cytoge-
netic abnormalities were detected in the 11p15 region.
Both patients 1 and 2 were examined by the authors.
There are reportedly two additional individuals in this
family affected with hemihyperplasia. One is a maternal
first cousin to both patients 1 and 2 who is currently in
Tunisia (III:7), whom by report has hemihyperplasia
affecting the left leg. She is currently 10 years old and said
to have no other manifestations besides her limb asym-
metry. She also has normal development. She has no his-
tory of neoplasm and is currently undergoing abdominal
ultrasound screening. Unfortunately she is unavailable for
examination. The maternal grandfather (I:1), also una-
vailable for direct examination, is reported to have hemi-
hyperplasia of the extremities on the right leg with no
other obvious manifestations. He is currently 50 years old
and lives in Tunisia. There is no consanguinity in this fam-
ily. The family pedigree is shown in Figure 2.
Conclusions
We have identified a family with four individuals affected
with isolated hemihyperplasia. We have examined two
members of the family while the two other are not availa-
ble for direct physical examination. The transmission of
the hemihyperplasia in this family could be compatible
with autosomal dominant inheritance with incomplete
penetrance, but given what we know about BWS, we pro-
pose that the hemihyperplasia in this family could also be
the result of an imprinting defect. Of the familial cases of
hemihyperplasia in the literature, seven had direct parent
to child transmission [9,11,12,14-16]. However, in many
of these families additional findings were also reported.
Scott [9] described a family in which the mother and
daughter were affected with hemihyperplasia but, in addi-
tion, the daughter had congenital heart disease and nevi.
Morris and MacGillivray [12] also described a family in
which both the mother and daughter were affected withBMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/1
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hemihyperplasia but both individuals had mental retar-
dation in addition as well as a psychiatric disorder. The
mother was noted to have pigmented lesions while the
daughter had pes cavus. Slavotinek et al. [17] reported a
mother and son with apparent isolated hemihypertrophy.
The presentation was unusual, however, in that the chest
asymmetry in the son and the leg length discrepancy in
the mother were not noted until adolescence. Stoll et al.
[15] reported a mother and daughter with hemihyperlasia
and in addition the daughter was noted to have an extra
nipple. There have been three families reported with par-
ent to child transmission of hemihyperplasia involving
the face only. Rudolph and Norvold [11] reported a child,
mother and grandmother each with facial asymmetry.
Bencze et al. [16] described a three-generation family with
apparent autosomal dominant transmission of facial
hemihyperplasia and strabismus. Burchfield and Escobar
[14] reported a family with father to son transmission of
facial asymmetry and severe malocclusion. Several other
family members were also affected. The family described
by Burchfield and Escobar is unique in that it is the only
family described with known male-to-male transmission,
in all other families the affected individuals were related
through the maternal lineage.
In addition to the families described with parent to child
transmission, there have been three reports of siblings
with hemihyperplasia. One case reported two sisters with
complete left-sided hemihyperplasia, however they addi-
tionally had significant mental retardation [12]. In this
family, their maternal grandmother apparently had left
facial hemihyperplasia but did not have mental retarda-
tion therefore it is unclear if the retardation was an unre-
lated finding. One other reported family showed a brother
and sister with complete right-sided hemihyperplasia [8].
The brother had a history of seizures and the sister had
mental retardation, nevi and strabismus. Fraumeni et al.
reported a family in which a female presented with right-
sided hemihyperplasia of the arm, leg and tongue as well
as a Wilms tumor of the left kidney [13]. Her brother had
right-sided hemihyperplasia of the leg. Furthermore, a
maternal uncle was reported as having his right leg longer
than his left leg. Lastly, Arnold [10] reported a nephew
and uncle with possible hemihyperplasia. The male child
had right-sided hemiacromegaly with early eruption of
several permanent teeth and his maternal uncle was also
said to have an "enlarged right cheek", the authors state
that he was not evaluated clinically.
These reported families do not point to a clear inheritance
pattern of transmission in hemihyperplasia. In all but one
reported family [14], the transmission of hemihyperplasia
occurred through maternal relatives. It must be noted
though that in several cases there were other abnormali-
ties present besides the body asymmetry, suggesting that
these families may not truly qualify for isolated hemihy-
perplasia. In the family we present, there are clearly two
maternal cousins with isolated hemihyperplasia present-
ing in infancy. One cousin developed Wilms tumor. Both
individuals were examined and clearly did not fit diagnos-
tic criteria for any syndromic form of hemihyperplasia.
It has been suggested that isolated hemihyperplasia may
be part of the BWS spectrum [3]. BWS is a syndrome of pre
Patient 2 with hemihyperplasia involving the upper and lower  right extremities Figure 1
Patient 2 with hemihyperplasia involving the upper and lower 
right extremities. The leg length discrepancy can be noted by 
the pelvic tilt.BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/1
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and post-natal overgrowth, macroglossia, omphalocele,
neonatal hypoglycemia and hemihyperplasia. The etiol-
ogy of BWS is complex and thought to be the result of a
genomic imprinting defect [7,18,19]. Genomic imprint-
ing refers to an epigenetic phenomenon characterized by
monoallelic expression of a gene depending on its parent
of origin [20]. The mechanisms leading to imprinting are
complex and consist of a parental specific mark or imprint
that is established in gametogenesis. This imprint mark
must be switchable when transmission occurs through
members of the opposite sex, for example from a mother
to her son. Although the exact molecular mechanisms for
BWS still remain elusive, several genetic mechanisms have
been postulated as probable cause [19,21,22]. BWS
appears to be associated with abnormal expression of a
gene/s on chromosome 11p15, which is one of the few
imprinted regions of the human genome. The paternally
expressed genes on 11p15 include: Insulin Growth Factor
2 (IGF2) that is a growth promoter, and KCNQ1-overlap-
ping transcript 1 (KCNQ1OT1  or  LIT1) .  S o m e  o f  t h e
maternally expressed genes include cyclin-dependent
kinase inhibitor 1C (CDKN1C) a cell cycle inhibitor also
known as p57(KIP2); KCNQ1, a potassium channel, volt-
age-gated gene also known as KvLQT1, and H19 that
codes for an untranslated RNA [20]. The region is further
divided into two distinct domains. Domain 1 contains
IGF2 and H19, and Domain 2 contains CDKN1C,
KCNQ1OT1, and KCNQ1. In addition, these two domains
are apparently regulated by two distinct imprinting cent-
ers. The imprinting centers are thought to maintain the
imprints in somatic cells but also play a role in resetting
the imprint in the germline [23]. The genetic lesions
described thus far in BWS include paternal duplications of
11p15, maternal translocations that disrupt the 11p15
region and mutations of CDKN1C. However, the majority
of BWS cases have no identifiable genetic alteration. It is
believed that most cases of BWS are caused by epigenetic
factors. One such situation is paternal uniparental disomy
of 11p15 that occurs in 10–20% of BWS cases [21]. Even
though the genetic and epigenetic mechanisms involved
in BWS are quite complex and not fully understood, it is
widely accepted that BWS results from dysregulation of
several closely linked genes on 11p15 which are involved
in cell cycle regulation and growth control. Further sup-
portive evidence can be surmised from evaluation of
maternal duplications of 11p15. Recently, Fisher et al.
[24] reported the first three cases of maternal duplications
of the BWS region. The phenotype in these three patients
included growth retardation, in contrast to the character-
istic overgrowth seen in paternal duplications of this
region (BWS). Another study looked at epigenetic altera-
tions of H19 and LIT1 in BWS patients [25]. In this partic-
ular cohort of patients, 92 children with BWS were studied
molecularly showing some interesting results. 39 out of
the 92 children studied (42%) had an altered methylation
pattern of LIT1 with normal H19 methylation, 10 out the
92 (11%) had an abnormal methylation pattern of H19
with normal LIT1, and 12 out of the 92 (13%) had altered
Pedigree Figure 2
Pedigree. III-1, III-3, II-2, and II-6 were examined by the authors.BMC Medical Genetics 2004, 5 http://www.biomedcentral.com/1471-2350/5/1
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methylation on both H19 and LIT1. From this last group,
only 9 have paternal UPD, which was somehow expected,
but the remaining 3 had biparental inheritance for the
11p15 region. This result strongly suggests the role of epi-
genetic mutations in BWS. Interestingly, in this group
with abnormal methylation for both H19 and LIT1, as
well as in those cases with paternal UPD for the 11p15
region, there was a higher incidence for hemihyperplasia.
The association of UPD and hemihyperplasia in BWS has
also been supported but previous clinical-molecular
studies.
Although BWS usually is sporadic, there have been several
families described with autosomal dominant inheritance.
CDKN1C mutations account for a larger portion of famil-
ial cases of BWS than sporadic cases, but the mechanism
for the majority of cases is still unknown. Viljoen et al. [7]
described a family with BWS, and reviewed 27 kindred's
with familial BWS reported thus far in the literature and in
all but four cases; the inheritance pattern was potentially
consistent with an imprinting defect.
The transmission pattern of hemihyperplasia in the family
presented here could also be consistent with a similar
imprinting mechanism. The maternal grandfather (I-1) of
the two male cousins discussed here (III-1 and III-3), is
reported to have hemihyperplasia. If we assume that I-1
has an imprinting abnormality (such that of IGF2 itself or
of it's imprinting center) of his maternally derived allele
that allows over expression of a growth-promoting factor
such as IGF2, this could lead to hemihyperplasia. His
maternal allele should normally be silent and now is
active secondary to an epigenetic defect. This individual
will also have his paternal copy that would result in func-
tional duplication and over expression of the IGF2 genes.
If this mutated allele was then transmitted from the grand-
father to his daughters (II2, II6 and II9), it would behave
normally, since a paternal allele would normally express
IGF2. These individuals would not be affected but would
be potential carriers. They have now the paternal "active"
allele and the maternally silent allele. These individuals
would then have a 50% chance of passing this abnormally
imprinted allele to their offspring. During gametogenesis
in individuals II2, II6 and II9 the imprinting mark on this
allele should be changed to a maternal, "silent" pattern.
However, if a particular epigenetic change renders this
allele unable to be reverted back to its silent form, it will
continue to have a paternal pattern of expression. In this
case the offspring that inherit this allele will now have a
net gain overexpression of a growth promoter such as
IGF2 therefore leading in this case to hemihyperplasia.
Certainly, loss of IGF2 imprinting is not the only possibil-
ity in this family, as the molecular mechanisms and inter-
actions of the imprinted genes on 11p15 are quite
complex, but the molecular mechanism (abnormal
imprinting) proposed in this family, could be consistent
with the paternal imprint model as proposed for familial
BWS. The other families reported in the literature with
hemihyperplasia showing autosomal dominant inherit-
ance and maternal transmission could also be consistent
with an imprinting mutation as well, (although they
could be more consistent with a maternal imprint)
[9,11,12,15]. Cytogenetic analysis was performed in three
of these families [15] ruling out the possibility of mater-
nal translocations, however, this cannot be completely
ruled out in the other families. Moreover, it is unclear
whether some of the other families reported in the litera-
ture can be considered as isolated hemihyperplasia as
there are other abnormalities found in these individuals.
Not all the reported families however would fit with an
imprinting pattern of inheritance [13], but as the majority
cases for BWS and hemihyperplasia remains unknown,
these families could represent different molecular mecha-
nisms caused by disturbance of balance between growth
promoters and suppressors. Similarly, the reported fami-
lies with isolated facial hemihyperplasia [14,16] do not fit
with an imprinting pattern of inheritance. In summary,
hemihyperplasia and similarly to what is seen BWS, is a
heterogenoeus group of disorders possibly caused by dif-
ferent molecular mechanisms. In the family presented in
this paper is certainly interesting to hypothesize a paternal
imprint defect. This additional family also raises caution
when counseling is done to these individuals. A good
family history with particular attention to overgrowth is
warranted in these patients. We believe that clinicians
should continue quoting a low recurrence risk for hemi-
hyperplasia, however, the rare possibility of familial recur-
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